MGTX
MeiraGTx Holdings plc
Key Financials
Revenue
$81.4M
↑ 144.6%
Operating Income
$-105968000
↑ 35.5%
Net Income
$-114201000
↑ 22.7%
EPS (Diluted)
$-1.42
↑ 33.0%
Total Assets
$244.4M
↓ 9.4%
Shareholders' Equity
$-5793000.00
↓ 108.5%
Total Liabilities
$250.2M
↑ 23.9%
Cash & Equivalents
$65.9M
↓ 36.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/24/2026 | View on SEC |
| 3 | 9/24/2026 | View on SEC |
| 8-K | 9/23/2026 | View on SEC |
| 4 | 8/18/2026 | View on SEC |
| 144 | 8/18/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| S-8 | 8/13/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 4 | 7/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MGTX |
| Company Name | MeiraGTx Holdings plc |
| CIK | 1735438 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 646-860-7985 |